Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shrankhla Maheshwari
Institutions:
National Institutes of Health,
National Cancer Institute
Observed institutions:
National Institutes of Health,
Central Drug Research Institute,
National Cancer Institute,
Council of Scientific and Industrial Research,
Academy of Scientific and Innovative Research
OpenAlex ID:
A5032561478
Tumor heterogeneity and cancer stem cell paradigm: Updates in concept, controversies and clinical relevance
2014
·
Anup Kumar Singh
, Rakesh Kumar Arya
, et al.
·
International Journal of Cancer
·
153
PDF
Anti-breast tumor activity of Eclipta extract in-vitro and in-vivo: novel evidence of endoplasmic reticulum specific localization of Hsp60 during apoptosis
2015
·
Rakesh K. Arya
, Akhilesh Singh
, et al.
·
Scientific Reports
·
70
PDF
CXCR4 intracellular protein promotes drug resistance and tumorigenic potential by inversely regulating the expression of Death Receptor 5
2021
·
Mushtaq A. Nengroo
, Shrankhla Maheshwari
, et al.
·
Cell Death and Disease
·
56
PDF
Salinomycin inhibits epigenetic modulator EZH2 to enhance death receptors in colon cancer stem cells
2020
·
Anup Kumar Singh
, Ayushi Verma
, et al.
·
Epigenetics
·
30
PDF
Discovery of a Novel Small-Molecule Inhibitor that Targets PP2A–β-Catenin Signaling and Restricts Tumor Growth and Metastasis
2017
·
Shrankhla Maheshwari
, Srinivasa R. Avula
, et al.
·
Molecular Cancer Therapeutics
·
30
Exosomes: Emerging Players of Intercellular Communication in Tumor Microenvironment
2014
·
Shrankhla Maheshwari
, Anup Kumar Singh
, et al.
·
Discoveries
·
28
PDF
Dual targeting of MDM2 with a novel small-molecule inhibitor overcomes TRAIL resistance in cancer
2016
·
Anup Kumar Singh
, Shikha S. Chauhan
, et al.
·
Carcinogenesis
·
22
CX-5461 induces radiosensitization through modification of the DNA damage response and not inhibition of RNA polymerase I
2022
·
Stacey L. Lehman
, Kayla R. Schwartz
, et al.
·
Scientific Reports
·
13
PDF
Supplementary Information from Discovery of a Novel Small-Molecule Inhibitor that Targets PP2A–β-Catenin Signaling and Restricts Tumor Growth and Metastasis
2023
·
Shrankhla Maheshwari
, Srinivasa R. Avula
, et al.
PDF
Data from Discovery of a Novel Small-Molecule Inhibitor that Targets PP2A–β-Catenin Signaling and Restricts Tumor Growth and Metastasis
2023
·
Shrankhla Maheshwari
, Srinivasa R. Avula
, et al.
Data from Discovery of a Novel Small-Molecule Inhibitor that Targets PP2A–β-Catenin Signaling and Restricts Tumor Growth and Metastasis
2023
·
Shrankhla Maheshwari
, Srinivasa R. Avula
, et al.
Abstract 6325: CXCR4 intracellular protein regulates chemotherapy resistance by modulating the expression of death receptor 5
2020
·
Mushtaq Ahmad Nengroo
, Shrankhla Maheshwari
, et al.
·
Cancer Research
Show more works
View as search
Works count:
13
Citation count:
402
H-index:
8
I10-index:
8
Year
Topic
Type